Mycobacterium tuberculosis dihydrofolate reductase is a target for isoniazid
- 30 April 2006
- journal article
- Published by Springer Science and Business Media LLC in Nature Structural & Molecular Biology
- Vol. 13 (5), 408-413
- https://doi.org/10.1038/nsmb1089
Abstract
Isoniazid is a key drug used in the treatment of tuberculosis. Isoniazid is a pro-drug, which, after activation by the katG-encoded catalase peroxidase, reacts nonenzymatically with NAD(+) and NADP(+) to generate several isonicotinoyl adducts of these pyridine nucleotides. One of these, the acyclic 4S isomer of isoniazid-NAD, targets the inhA-encoded enoyl-ACP reductase, an enzyme essential for mycolic acid biosynthesis in Mycobacterium tuberculosis. Here we show that the acyclic 4R isomer of isoniazid-NADP inhibits the M. tuberculosis dihydrofolate reductase (DHFR), an enzyme essential for nucleic acid synthesis. This biologically relevant form of the isoniazid adduct is a subnanomolar bisubstrate inhibitor of M. tuberculosis DHFR. Expression of M. tuberculosis DHFR in Mycobacterium smegmatis mc(2)155 protects cells against growth inhibition by isoniazid by sequestering the drug. Thus, M. tuberculosis DHFR is the first new target for isoniazid identified in the last decade.Keywords
This publication has 31 references indexed in Scilit:
- Quantitative Proteomic Analysis of Drug-Induced Changes in MycobacteriaJournal of Proteome Research, 2005
- Structure, Dynamics, and Catalytic Function of Dihydrofolate ReductaseAnnual Review of Biophysics and Biophysical Chemistry, 2004
- Signature Gene Expression Profiles Discriminate between Isoniazid-, Thiolactomycin-, and Triclosan-Treated Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 2003
- Three-dimensional structure of M. tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugsJournal of Molecular Biology, 2000
- Stretching exercises — flexibility in dihydrofolate reductase catalysisCell Chemical Biology, 1998
- Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosisScience, 1998
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D-Biological Crystallography, 1994
- Tuberculosis: Commentary on a Reemergent KillerScience, 1992
- The catalase—peroxidase gene and isoniazid resistance of Mycobacterium tuberculosisNature, 1992
- Kinetic mechanism of the reaction catalyzed by dihydrofolate reductase from Escherichia coliBiochemistry, 1982